Laura Brooks
AstraZeneca (United Kingdom)(GB)AstraZeneca (France)(FR)AstraZeneca (Switzerland)(CH)
Publications by Year
Research Areas
Asthma and respiratory diseases, Tracheal and airway disorders, Dysphagia Assessment and Management, Eosinophilic Esophagitis, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies(2019)112 cited
- → Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis(2024)82 cited
- → Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy(2013)64 cited
- → Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma(2021)49 cited
- → <p>Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma</p>(2019)48 cited
- → Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma(2019)44 cited